Health CS suspends Kemsa CEO Terry Ramadhani

The CS has now appointed Andrew Mutava Mulwa as the new acting CEO

In Summary
  •  The CS has now appointed Andrew Mutava Mulwa as the new acting CEO. 
  • Further, Wafula directed the new management to assure propriety of procurement processes within the agency.
Health CS Susan Wafula at Afya House on Friday May 5, 2023/Handout
Health CS Susan Wafula at Afya House on Friday May 5, 2023/Handout

Health Cabinet Secretary  Susan Wafula has suspended Kemsa Chief Executive Officer Terry Ramadhani.

 
 
 

The Health CS suspended Ramadhani on Monday alongside other staff members serving within the Ministry of Health, National Malaria Programme and Kemsa. 

Those suspended are Martin Wamwea, Lenson Kariuki, Pauline Duya, Livingstone Njuguna, and Charles Kariuki Chege who were serving under the MoH National Malaria Programme.

She also kicked out Justus Kinoti, Cosmas Rotich and Anthony Chege from Kemsa. 

The CS has now appointed Andrew Mutava Mulwa as the Kemsa acting CEO.

"The Cabinet Secretary has appointed Dr Andrew Mutava Mulwa as the Acting Chief Executive Officer of Kenya Medical Supplies Authority," the document read. 

Additionally, Wafula reconstituted the Kemsa board by appointing the following people as members; Hezbon Oyieko Omollo,  Bernard Kipkirui Bett, Jane Masiga and Jane Nyagaturi Mbatia. 

Further, Wafula directed the new management to assure the propriety of procurement processes within the agency.

This comes after President William Ruto gave assurance that he will sort out the mess that has been ongoing at Kemsa.  

Ruto in a media interview on Sunday said he had been briefed on complaints of alleged impropriety within Kemsa in its management and administration. 

"I am doing something about it. You will see results. I want to give you my commitment, I will clean up KEMSA, whatever it takes, whatever it costs," he said on Sunday during a joint media interview. 

Kemsa has continued to make headlines over corruption and mismanagement. 

The most recent Sh3.7 billion mosquito net deal was marred with allegations of irregularities in the tendering process. 

The Global Fund had given Kemsa the deal which could see it earn Sh370 million in revenue through warehousing and transport logistics.

It however cancelled it citing irregularities in the procurement process.

The procurement process initiated by Kemsa saw the tender awarded to Shobikaa Impex and Partec East Africa Ltd.

Upon scrutiny, however, Shobikaa Impex did not reflect on the database of the Registrar of Companies.

Ramadhani however defended Kemsa saying Shobikaa was an Indian company which is why it did not reflect in the Kenyan database.

WATCH: The latest videos from the Star